Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
SCILAL Q3 FY26 Net Profit Rises 10% YoY to ₹11.13 Cr; Sequential PAT Jumps 165%
SCILAL reported a strong sequential recovery in net profit for Q3 FY26, reaching ₹11.13 crore compared to ₹4.19 crore in the previous quarter. While total income remained relatively flat year-on-year at ₹26.56 crore, a significant reduction in 'Other Expenses' helped boost the bottom line. The company's 'Others' segment, which manages investment properties and rental income, remains the primary profit driver, offsetting losses in the Maritime Training Institute (MTI) segment. The company maintains a healthy balance sheet with segment assets exceeding ₹3,534 crore.
Key Highlights
Net Profit increased by 9.8% YoY to ₹11.13 crore from ₹10.13 crore in the year-ago period.Profit Before Tax (PBT) saw a sharp sequential rise to ₹15.40 crore from ₹5.87 crore in Q2 FY26.Total expenses decreased significantly to ₹11.16 crore from ₹21.69 crore in the previous quarter.The 'Others' segment (Investment Property) contributed ₹17.08 crore to segment results, while the MTI segment reported a loss of ₹1.67 crore.Earnings Per Share (EPS) improved to ₹0.24 for the quarter, up from ₹0.09 in the preceding quarter.
👀 What to Watch
Investors should monitor the stability of rental and interest income from the 'Others' segment, which is the core value driver for this demerged entity. The stock remains a play on asset management and steady yields rather than operational growth in training services.
Motilal Oswal Receives 'Good' ICRA ESG Impact Rating of 76/100
Motilal Oswal Financial Services (MOFSL) has voluntarily obtained an ESG Impact Rating of 76 ('Good') from ICRA ESG Ratings Limited. The company achieved an 'Outstanding' score of 83 in the Social pillar, supported by CSR spending of ₹17.2 crore in FY2025, which exceeded the statutory requirement of ₹16.5 crore. While the Environmental (72) and Governance (75) scores are solid, the rating is constrained by a high frontline attrition rate of 70.9% and a significant pay disparity of 794x. This rating provides a benchmark for institutional investors focusing on sustainability and corporate responsibility.
Key Highlights
Overall ESG Impact Rating assigned at 76/100, categorized as 'Good' by ICRA.Social Pillar scored 83 ('Outstanding') driven by employee welfare and extensive CSR initiatives.CSR expenditure for FY2025 reached ₹17.2 crore, surpassing the ₹16.5 crore statutory mandate.Environmental score of 72 reflects a low carbon footprint (1.2 tCO2e/Rs. crore) but lacks renewable energy infrastructure.Governance score of 75 is supported by a long track record, though constrained by high executive-to-median pay disparity of 794x.
👀 What to Watch
Investors should recognize this voluntary disclosure as a commitment to transparency, which is likely to attract ESG-focused institutional capital. Monitor management's efforts to stabilize the 70.9% frontline attrition rate, as this remains a key operational constraint.
Motilal Oswal Q3FY26 Operating PAT Up 16% YoY to ₹611 Cr; Interim Dividend of ₹6 Declared
Motilal Oswal Financial Services reported a 16% YoY increase in operating PAT to ₹611 crores for Q3FY26, driven by a 32% growth in Asset and Private Wealth businesses. These annuity-style segments now contribute over 50% of the group's operating profit, with annual recurring revenue (ARR) reaching 65% of total net revenue. The company's Asset Management AUM grew 33% YoY to ₹1.89 lakh crores, while Private Wealth AUM rose 31% to ₹1.95 lakh crores. Reflecting strong performance, the board declared an interim dividend of ₹6 per share, a 20% increase from the previous year.
Key Highlights
Operating PAT grew 16% YoY to ₹611 crores; adjusted for new labor code impact, growth was 18%Asset Management AUM reached ₹1.89 lakh crores (up 33% YoY) with a record 2.7% market share in Mutual FundsPrivate Wealth Management AUM grew 31% YoY to ₹1.95 lakh crores, serving 8,200+ familiesHousing Finance AUM increased 24% YoY to ₹5,379 crores with stable asset quality (GNPA at 1.4%)Quarterly SIP flows crossed ₹4,500 crores, a 1.5x increase YoY, resulting in a 5% SIP market share
👀 What to Watch
Investors should favor the stock for its structural shift toward high-margin annuity businesses and strong AUM growth. The increasing share of recurring revenue and market share gains in the AMC segment provide a high degree of earnings visibility.
Dr. Lal PathLabs Q3 FY26 Revenue Up 10.6% to ₹660 Cr; Declares ₹3.5 Interim Dividend
Dr. Lal PathLabs reported a steady 10.6% YoY revenue growth for Q3 FY26, reaching ₹660 crore, despite a slowdown in patient volume growth to 2.7% due to a decline in seasonal fever cases. EBITDA before exceptional items grew 16.3% to ₹179 crore with a margin of 27.2%, though PAT was impacted by a one-time ₹30 crore charge for labor code implementation. The company remains focused on organic growth, targeting 11-12% for the full year, and has launched 'Sovaaka', a new preventive wellness platform. A ₹3.5 per share interim dividend was declared on the post-bonus equity base.
Key Highlights
Revenue for Q3 FY26 increased 10.6% YoY to ₹660 crore, with 9M FY26 revenue at ₹2,060 crore.EBITDA (pre-exceptional) rose 16.3% to ₹179 crore, maintaining a healthy margin of 27.2%.Revenue per patient grew 7.7% YoY to ₹927, driven by a favorable test mix and higher Swasthfit contribution (26%).Recognized a one-time exceptional cost of ₹30 crore related to the implementation of the new labor code.Maintains a strong balance sheet with net cash and cash equivalents of ₹1,411 crore as of December 2025.
👀 What to Watch
Investors should focus on the company's ability to scale its 'Sovaaka' wellness platform and recover patient volume growth in non-seasonal segments. The steady organic growth and strong cash position support long-term holding, though the impact of the new labor code on margins should be monitored.
Dr. Lal PathLabs Q3 Revenue up 10.6% to Rs 660 Cr; Declares Rs 3.5 Dividend
Dr. Lal PathLabs reported a steady 10.6% YoY revenue growth for Q3 FY26, reaching Rs 660 Cr. While operational EBITDA (before exceptional items) grew strongly by 16.3% with margins expanding to 27.2%, the bottom line was impacted by a one-time exceptional charge of Rs 30.1 Cr related to new labour codes. Consequently, reported PAT declined 6.8% YoY to Rs 91 Cr. The company maintains a robust cash position of Rs 1,411 Cr and declared an interim dividend of Rs 3.5 per share.
Key Highlights
Revenue grew 10.6% YoY to Rs 660 Cr in Q3 FY26, with 9M revenue up 10.8% to Rs 2,060 Cr.EBITDA before exceptional items rose 16.3% YoY to Rs 179 Cr, with margins improving to 27.2% from 25.8%.Reported PAT fell 6.8% YoY to Rs 91 Cr due to a Rs 30.1 Cr one-time exceptional impact from new Labour Codes.Strong liquidity position with cash and bank balances of Rs 1,411 Cr as of December 31, 2025.Board declared an interim dividend of Rs 3.5 per share for the quarter.
👀 What to Watch
Investors should focus on the healthy 16.3% growth in operational EBITDA and margin expansion, as the PAT decline is primarily due to a non-recurring exceptional item. The company's strong cash reserves and consistent dividend payout reflect financial stability.
Motilal Oswal Declares Interim Dividend of Rs 6 Per Share; Sets Record Date for Jan 31, 2026
Motilal Oswal Financial Services Limited has declared an interim dividend of Rs 6 per equity share for the Financial Year 2025-26. This dividend is calculated on a face value of Re 1 per share, representing a 600% payout. The company has fixed January 31, 2026, as the record date to identify eligible shareholders. The dividend distribution is expected to be completed by February 25, 2026, providing a timely cash return to investors.
Key Highlights
Interim dividend of Rs 6 per equity share declared for FY 2025-26Dividend payout is based on a face value of Re 1 per shareRecord date for determining shareholder eligibility is January 31, 2026Payment of the interim dividend will be completed on or before February 25, 2026
👀 What to Watch
Investors seeking dividend income should ensure they hold the stock before the ex-dividend date to qualify for the Rs 6 per share payout. The declaration reflects the company's strong profitability and commitment to shareholder returns.
Motilal Oswal Q3 FY26 Revenue Grows 17% YoY to ₹2,008 Cr; PAT Steady at ₹569 Cr
Motilal Oswal Financial Services reported a 17.4% year-on-year growth in consolidated revenue from operations, reaching ₹2,008.5 crore for the quarter ended December 31, 2025. While Profit After Tax (PAT) remained flat at ₹569.16 crore compared to the previous year, the Total Comprehensive Income saw a significant jump to ₹725.04 crore, driven by fair value gains. For the nine-month period, the company has achieved a substantial PAT of ₹2,508.18 crore. Additionally, the firm strengthened its capital position by raising ₹300 crore through the private placement of Non-Convertible Debentures (NCDs).
Key Highlights
Consolidated Revenue from operations increased 17.4% YoY to ₹2,008.5 crore in Q3 FY26.Profit After Tax (PAT) for the quarter stood at ₹569.16 crore, maintaining stability YoY.Total Comprehensive Income surged to ₹725.04 crore from ₹460.86 crore in the same quarter last year.Raised ₹300 crore through Private Placement of NCDs during the quarter for business operations.Nine-month EPS (Basic) reached a strong ₹41.83 per share.
👀 What to Watch
Investors should note the strong top-line growth and the significant boost in comprehensive income, which reflects well on the company's investment portfolio. The steady PAT despite rising revenues suggests a focus on scale, making it a solid hold for long-term exposure to the Indian capital markets.
Motilal Oswal Q3 FY26 Net Profit Rises 14% to ₹689 Cr; Declares ₹6 Interim Dividend
Motilal Oswal Financial Services reported a strong performance for Q3 FY26, with consolidated net profit growing 14% year-on-year to ₹689 crore. The Board has declared an interim dividend of ₹6 per share, reflecting healthy cash flows and commitment to shareholder returns. Total revenue from operations for the quarter stood at ₹2,065 crore, a significant jump from ₹1,720 crore in the same period last year. The company also successfully raised ₹300 crore via Non-Convertible Debentures (NCDs) during the quarter to support its business objectives.
Key Highlights
Consolidated Net Profit for Q3 FY26 increased to ₹689 crore from ₹605 crore in Q3 FY25.Total Revenue from operations grew by 20% YoY to ₹2,065 crore.Declared an interim dividend of ₹6 per equity share on a face value of ₹1 each.Successfully raised ₹300 crore through private placement of Non-Convertible Debentures (NCDs).Basic Earnings Per Share (EPS) for the quarter improved to ₹11.31 from ₹10.12 YoY.
👀 What to Watch
Investors should find the consistent growth in both top-line and bottom-line encouraging, alongside the healthy dividend payout. The stock remains a strong proxy for the Indian capital markets and wealth management sector.
Motilal Oswal Q3FY26 Operating PAT up 16% YoY to ₹611 Cr; Declares ₹6 Dividend
Motilal Oswal Financial Services reported its highest-ever quarterly operating PAT of ₹611 crore for Q3FY26, marking a 16% YoY growth. The Asset and Private Wealth Management segments were major drivers, contributing approximately 50% of the group's operating profit. Total Assets Under Advice (AUA) crossed the ₹7 lakh crore milestone, while the Treasury book grew to ₹9,562 crore with an 18.5% XIRR since inception. The company also declared an interim dividend of ₹6 per share, maintaining its consistent shareholder payout policy.
Key Highlights
Operating PAT grew 16% YoY to ₹611 Cr; Asset Management PAT surged 65% YoY to ₹227 Cr.Total Assets Under Advice (AUA) crossed ₹7 lakh Cr; Mutual Fund AUM grew 40% YoY.Treasury book reached ₹9,562 Cr with a healthy 18.5% XIRR since inception.Net worth increased to ₹13,632 Cr, representing a 24% CAGR over the last decade.Declared an interim dividend of ₹6 per equity share for the financial year.
👀 What to Watch
The significant shift towards high-margin, fee-based recurring revenue (74% of total) improves earnings stability and justifies a positive outlook. Investors should note the strong 26% ROE and the company's proven ability to compound net worth without external capital raises.
Motilal Oswal Financial Services (MOTILALOFS) reported a consolidated net profit of ₹569.16 crore for Q3 FY26, showing steady performance compared to ₹560.05 crore in the previous year. The company's total revenue from operations grew by approximately 11.9% year-on-year to ₹2,011.13 crore. A key highlight for shareholders is the declaration of an interim dividend of ₹6 per share (600% of face value). Additionally, the company successfully raised ₹300 crore through Non-Convertible Debentures (NCDs) during the quarter to bolster its capital position.
Key Highlights
Declared an interim dividend of ₹6 per equity share of face value ₹1 each for FY 2025-26.Consolidated revenue from operations rose to ₹2,011.13 crore in Q3 FY26 from ₹1,797.36 crore in Q3 FY25.Consolidated Net Profit for the quarter stood at ₹569.16 crore with a basic EPS of ₹9.42.Raised ₹300 crore through Private Placement of Non-Convertible Debentures (NCDs) during the quarter.Nine-month (9M FY26) consolidated net profit reached ₹2,100.61 crore.
👀 What to Watch
Investors should view the ₹6 interim dividend and steady revenue growth as signs of strong operational health. The stock remains a solid play in the diversified financial services sector with consistent shareholder payouts.
BLAL Reports Nil Revenue and Net Loss of ₹46.04 Lakhs for Q3 FY26
BEML Land Assets Limited (BLAL) reported zero revenue from operations for the quarter ended December 31, 2025, reflecting its nature as a holding company for non-core assets. The company posted a net loss of ₹46.04 lakhs for the quarter, compared to a loss of ₹44.03 lakhs in the corresponding quarter of the previous year. For the nine-month period ended December 2025, the net loss widened to ₹373.68 lakhs from ₹332.88 lakhs year-on-year. Additionally, the company noted a regulatory non-compliance regarding the insufficient number of independent directors on its board.
Key Highlights
Revenue from operations and total income remained at zero for the quarter ended December 31, 2025.Net loss for Q3 FY26 stood at ₹46.04 lakhs versus a loss of ₹44.03 lakhs in Q3 FY25.Total expenses for the nine-month period increased to ₹373.68 lakhs from ₹332.88 lakhs in the previous year.Negative reserves widened to ₹4,426.97 lakhs as of December 31, 2025, compared to ₹4,011.43 lakhs a year ago.The company is currently non-compliant with SEBI Listing Regulations regarding the required number of Independent Directors.
👀 What to Watch
As BLAL is a demerged entity holding surplus land assets, investors should focus on land monetization progress rather than quarterly earnings. The current lack of revenue and widening losses make the stock a speculative play on asset valuation.
Dr. Lal PathLabs Launches SOVAAKA Wellness Centre to Expand into Premium Preventive Care
Dr. Lal PathLabs has launched SOVAAKA, a premium wellness center in Gurugram, marking its entry into the high-growth preventive healthcare segment. The facility integrates advanced diagnostics like 1.5T MRI and genetic testing with AI-driven insights to offer personalized health programs. This strategic move aims to transition the company from disease detection to predictive wellness, targeting higher-margin lifestyle disease management. As of March 2025, the company operates 298 labs and over 6,607 service centers, providing a strong foundation for scaling such premium initiatives.
Key Highlights
Launched SOVAAKA in Gurugram, a next-generation wellness center blending science and AI technology.Equipped with high-end diagnostic tools including 1.5T MRI, low-dose CT, and DEXA scanning.Offers specialized, doctor-designed programs like Eterna for women and Vita for men.Strategic focus on the growing preventive health market to address rising Non-Communicable Diseases.Company network includes 298 clinical labs and 12,365 pick-up points as of March 31, 2025.
👀 What to Watch
This expansion into premium wellness is a positive move to increase average revenue per patient; investors should watch for further rollouts of this format in other metros.
Motilal Oswal Shareholders Approve New Director Appointments with Over 99% Majority
Motilal Oswal Financial Services Limited (MOTILALOFS) has announced the successful passage of six key resolutions via postal ballot as of December 30, 2025. Shareholders approved the appointment and remuneration of Mr. Pratik Oswal and Mr. Vaibhav Agrawal as Non-Executive Directors. Additionally, two new Independent Directors, Mr. Joseph Conrad Agnelo D’Souza and Mr. Ashok Kumar Parasmal Kothari, were appointed to the board. All resolutions received overwhelming support, with most passing with over 99% of the votes in favor.
Key Highlights
Appointment of Mr. Pratik Oswal as Non-Executive Director approved with 99.54% votes in favor.Appointment of Mr. Vaibhav Agrawal as Non-Executive Director approved with 99.33% votes in favor.Remuneration approvals for both Pratik Oswal and Vaibhav Agrawal received over 99.8% support from voting shareholders.Two new Independent Directors were appointed via special resolutions to strengthen board governance.A total of 2,41,544 shareholders were eligible for voting as of the November 21, 2025 cut-off date.
👀 What to Watch
These appointments represent a planned evolution of the company's leadership and governance; investors should view this as a routine strengthening of the board and no immediate action is required.
SCILAL Extends Capt. B. K. Tyagi's Additional Charge as CMD for 6 Months
The Ministry of Ports, Shipping and Waterways has approved the extension of Capt. B. K. Tyagi's additional charge as Chairman and Managing Director (CMD) of SCILAL. The extension is effective for a six-month period from January 1, 2026, to June 30, 2026, or until further orders. Capt. Tyagi, who is also the CMD of Shipping Corporation of India (SCI), brings over 35 years of industry experience to the role. This move ensures leadership continuity for the company, which manages the non-core land and assets demerged from SCI.
Key Highlights
Extension of Capt. B. K. Tyagi's additional charge as CMD for a 6-month period.New term effective from January 1, 2026, through June 30, 2026.Capt. Tyagi concurrently serves as CMD of Shipping Corporation of India (SCI).Appointment is subject to final approval from the Appointments Committee of the Cabinet (ACC).Capt. Tyagi has over 35 years of experience in shipping, navigation, and general management.
👀 What to Watch
This is a routine administrative extension ensuring leadership stability. Investors should monitor for any future announcements regarding a permanent CMD appointment for the demerged entity.
Dr. Lal Path Labs Allots 8.37 Crore Bonus Shares in 1:1 Ratio
Dr. Lal Path Labs has completed the allotment of 8,37,75,510 bonus equity shares to eligible shareholders following its 1:1 bonus issue. The allotment was approved via a circular resolution on December 22, 2025, for shareholders on record as of December 19, 2025. This move doubles the company's total number of outstanding shares to 16,75,51,020. The paid-up equity share capital now stands increased at INR 167.55 crore, with the new shares ranking pari-passu with existing ones.
Key Highlights
Allotment of 8,37,75,510 fully paid-up bonus equity shares of face value INR 10 each.Bonus issue executed in a 1:1 ratio for shareholders as of the December 19, 2025 record date.Total paid-up equity capital increased from INR 83.77 crore to INR 167.55 crore.Total number of equity shares outstanding increased to 16,75,51,020 shares.New bonus shares rank pari-passu in all respects with existing equity shares.
👀 What to Watch
Investors should note that while the number of shares in their portfolio has doubled, the stock price has been adjusted proportionally. No further action is required as the allotment is automatic for eligible shareholders.
Dr. Lal Path Labs Sets Dec 19 as Record Date for 1:1 Bonus Issue
Dr. Lal Path Labs Ltd. has officially fixed Friday, December 19, 2025, as the record date for its 1:1 bonus share issue. Eligible shareholders will receive one new fully paid-up equity share of INR 10 for every one existing share held. The deemed date for the allotment of these bonus shares is scheduled for December 22, 2025. This corporate action follows the approval previously granted by the company's members on December 08, 2025.
Key Highlights
Bonus issue ratio confirmed at 1:1 (one new share for every one existing share).Record date for determining shareholder eligibility is December 19, 2025.Deemed date of allotment for the bonus equity shares is December 22, 2025.The face value of the equity shares remains unchanged at INR 10 per share.
👀 What to Watch
Investors should note that the stock price will adjust downward on the ex-bonus date to reflect the 1:1 ratio, while their total shareholding will double. To be eligible for the bonus, shares must be purchased before the ex-date.
MOTILALOFS Allots 30,000 NCDs aggregating to ₹300 Crore
Motilal Oswal Financial Services Limited has announced the allotment of 30,000 fully paid, secured, rated, redeemable, listed, senior Non-Convertible Debentures (NCDs). The face value of each NCD is ₹1,00,000, aggregating to a total issue size of ₹300 Crore. These NCDs are proposed to be listed on the National Stock Exchange of India Limited (NSE). The tenure of the instrument is 3 years, maturing on December 12, 2028, with coupon payments annually.
Key Highlights
Allotted 30,000 Secured NCDsEach NCD has a face value of ₹1,00,000Total issue size aggregates to ₹300 CroreNCDs mature on December 12, 2028Coupon payments are scheduled annually
👀 What to Watch
Investors should review the terms of the NCDs, including the coupon rate and security details, as outlined in the General Information Document (GID) and Key Information Document (KID). Monitor the company's ability to maintain a minimum security cover of 1.00 times the outstanding principal amounts of the NCDs.
Dr. Lal PathLabs Q2 FY26 Net Profit Rises 16.4% YoY to ₹152 Cr; 1:1 Bonus Issue Approved
Dr. Lal PathLabs reported a steady performance for Q2 FY26, with revenue from operations growing 10.7% YoY to ₹730.6 crore. Net profit for the quarter increased by 16.4% YoY to ₹152.2 crore, supported by a 10.8% growth in H1 revenue reaching ₹1,400.4 crore. The company's board has approved a 1:1 bonus issue and a second interim dividend of ₹7 per share, reflecting strong cash flows and management confidence. Operational highlights include the successful integration of Suburban Diagnostics' business into the parent entity following its voluntary liquidation.
Key Highlights
Revenue from operations increased 10.7% YoY to ₹7,306 million in Q2 FY26.Consolidated Net Profit rose 16.4% YoY to ₹1,522 million compared to ₹1,308 million in the previous year.Board approved a 1:1 bonus issue (one bonus share for every one share held) subject to shareholder approval.Declared a second interim dividend of ₹7 per equity share for FY26.Basic Earnings Per Share (EPS) improved to ₹18.05 from ₹15.52 in the same quarter last year.
👀 What to Watch
The consistent double-digit growth in profit and the announcement of a 1:1 bonus issue are strong positive signals for long-term investors. Maintain a positive outlook on the stock while monitoring the integration benefits of the Suburban Diagnostics business.
Dr. Lal PathLabs Increases Authorized Share Capital to INR 200 Crore
Dr. Lal PathLabs has received shareholder approval via postal ballot to significantly increase its authorized share capital. The limit has been raised from INR 107.96 crore to INR 200 crore, effectively doubling the company's capacity to issue new equity. This change involves a formal amendment to Clause V of the Memorandum of Association. While this is a regulatory enabling provision, it often serves as a precursor to future corporate actions such as bonus issues, rights issues, or equity-based fundraising.
Key Highlights
Authorized share capital increased from INR 107.96 crore to INR 200 crore.Shareholder approval was obtained through a postal ballot concluded on December 07, 2025.The new capital structure consists of 20,00,00,000 equity shares with a face value of INR 10 each.Amendment to Clause V of the Memorandum of Association (MOA) has been officially implemented.
👀 What to Watch
Investors should monitor the company for upcoming announcements regarding bonus issues or capital raises, as this move creates the necessary legal headroom for such actions.
Dr. Lal PathLabs Shareholders Approve Bonus Issue and New 2025 Employee Stock Unit Plan
Dr. Lal PathLabs has announced the successful passage of seven resolutions via postal ballot, most notably the issuance of bonus equity shares and an increase in authorized share capital. The 'Employee Restricted Stock Unit Plan 2025' was approved with 79.81% favor, although it faced significant institutional dissent with 51.5% of institutional votes cast against it. Additionally, shareholders cleared the path for secondary share acquisitions through a trust and a reduction in the 2022 options reserve. These approvals facilitate the company's capital restructuring and long-term incentive programs.
Key Highlights
Bonus Equity Shares issuance approved with 98.04% of total votes in favor.Increase in Authorized Share Capital passed with a near-unanimous 99.84% majority.New 'Employee Restricted Stock Unit Plan 2025' secured 79.81% support despite 51.5% institutional pushback.Secondary acquisition of shares through a Trust route for ESOP implementation approved by 83.76% of voters.Reduction of Options Reserve under the 2022 ESOP plan approved with 86.80% majority.
👀 What to Watch
Investors should view the bonus issue as a positive move for share liquidity, though the high institutional dissent on the new ESOP plan suggests a need to monitor future management compensation and dilution.
⚠️How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI
⚡ Free FlashFinance Newsletters
AI-powered market intelligence in your inbox — completely free. Pick your topics; max 1 email per topic per day. Unsubscribe anytime.
✅ Everything below is 100% free — no payment, no card, ever.
🎉
You're subscribed!
A welcome email with your topics is on its way. Want it even faster? Join us on Telegram or WhatsApp:
